Profile	GDS3514 / 208384_s_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	819.934	68
GSM325241	Patient no. 1: treated	1208.52	76
GSM325242	Patient no. 9: control	1856.7	85
GSM325243	Patient no. 9: treated	1516.08	82
GSM325244	Patient no. 18: control	668.74	64
GSM325245	Patient no. 18: treated	788.329	68
GSM325246	Patient no. 12: control	903.212	73
GSM325247	Patient no. 12: treated	891.616	73
GSM325248	Patient no. 3: control	843.716	69
GSM325249	Patient no. 3: treated	1098.32	74
GSM325250	Patient no. 7: control	860.46	72
GSM325251	Patient no. 7: treated	795.659	71
GSM325252	Patient no. 15: control	868.941	70
GSM325253	Patient no. 15: treated	930.968	72
GSM325254	Patient no. 4: control	495.766	58
GSM325255	Patient no. 4: treated	683.153	64
GSM325256	Patient no. 19: control	669.423	67
GSM325257	Patient no. 19: treated	596.795	65
GSM325258	Patient no. 14: control	954.626	73
GSM325259	Patient no. 14: treated	949.739	72
GSM325260	Patient no. 13: control	1138.33	76
GSM325261	Patient no. 13: treated	1144.06	76
GSM325262	Patient no. 17: control	620.037	62
GSM325263	Patient no. 17: treated	703.677	66
GSM325264	Patient no. 10: control	783.302	69
GSM325265	Patient no. 10: treated	934.759	72
GSM325266	Patient no. 5: control	538.239	61
GSM325267	Patient no. 5: treated	1174.66	77
GSM325268	Patient no. 11: control	1141.91	75
GSM325269	Patient no. 11: treated	1182.57	77
GSM325270	Patient no. 6: control	1730.22	84
GSM325271	Patient no. 6: treated	1569.23	82
GSM325272	Patient no. 8: control	909.534	72
GSM325273	Patient no. 8: treated	1060.86	75
GSM325274	Patient no. 16: control	474.775	57
GSM325275	Patient no. 16: treated	897.943	73
GSM325276	Patient no. 2: control	780.701	66
GSM325277	Patient no. 2: treated	677.212	68